These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 33858488

  • 21. Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.
    Lally J, Tully J, Robertson D, Stubbs B, Gaughran F, MacCabe JH.
    Schizophr Res; 2016 Mar; 171(1-3):215-24. PubMed ID: 26827129
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study.
    Arumugham SS, Praharaj SK, Shreekantiah U, Sreeraj VS, Roy C, Shenoy S, Purohith AN, Chithra U, Bagali KB, Venkataramaiah S, Nanjundaiah GKK, Thennarasu K, Kumar CN, Goyal N, Das B, Mehta UM, Muralidharan K, Venkatasubramanian G, Sinha P, Thirthalli J.
    Wellcome Open Res; 2022 Mar; 7():212. PubMed ID: 37953926
    [Abstract] [Full Text] [Related]

  • 26. Combined use of clozapine and ECT: a review.
    Grover S, Hazari N, Kate N.
    Acta Neuropsychiatr; 2015 Jun; 27(3):131-42. PubMed ID: 25697225
    [Abstract] [Full Text] [Related]

  • 27. The augmentation of clozapine treatment with electroconvulsive therapy.
    Gazdag G, Kocsis-Ficzere N, Tolna J.
    Ideggyogy Sz; 2006 Jul 20; 59(7-8):261-7. PubMed ID: 17076304
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe S, French P, Hutton P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TR, Davies L, Shields G, Buck D, Tully S, Kingdon D.
    Health Technol Assess; 2019 Feb 20; 23(7):1-144. PubMed ID: 30806619
    [Abstract] [Full Text] [Related]

  • 31. Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count.
    Sugita K, Mori Y, Kanemoto K, Sugita S.
    Sci Prog; 2022 Feb 20; 105(3):368504221117067. PubMed ID: 36000301
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Grover S, Chakrabarti S, Hazari N, Avasthi A.
    Psychiatry Res; 2017 Mar 20; 249():349-353. PubMed ID: 28152470
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
    Gunduz-Bruce H, Oliver S, Gueorguieva R, Forselius-Bielen K, D'Souza DC, Zimolo Z, Tek C, Kaliora S, Ray S, Petrides G.
    Schizophr Res; 2013 Feb 20; 143(2-3):344-7. PubMed ID: 23219861
    [Abstract] [Full Text] [Related]

  • 34. Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature.
    Sanghani SN, Petrides G, Kellner CH.
    Curr Opin Psychiatry; 2018 May 20; 31(3):213-222. PubMed ID: 29528902
    [Abstract] [Full Text] [Related]

  • 35. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients.
    Masoudzadeh A, Khalilian AR.
    Pak J Biol Sci; 2007 Dec 01; 10(23):4287-90. PubMed ID: 19086588
    [Abstract] [Full Text] [Related]

  • 36. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E, Kane JM, Correll CU, Howes O, Siskind D, Honer WG, Lee J, Falkai P, Schneider-Axmann T, Hasan A, TRRIP Working Group.
    Schizophr Bull; 2020 Dec 01; 46(6):1459-1470. PubMed ID: 32421188
    [Abstract] [Full Text] [Related]

  • 37. Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report.
    Ito M, Kunii Y, Horikoshi S, Miura I, Itagaki S, Shiga T, Yabe H.
    Int Med Case Rep J; 2019 Dec 01; 12():185-188. PubMed ID: 31297000
    [Abstract] [Full Text] [Related]

  • 38. Combined electroconvulsive-clozapine therapy.
    Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M.
    Clin Neuropharmacol; 2000 Dec 01; 23(1):14-6. PubMed ID: 10682225
    [Abstract] [Full Text] [Related]

  • 39. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.
    Health Technol Assess; 2017 Sep 01; 21(49):1-56. PubMed ID: 28869006
    [Abstract] [Full Text] [Related]

  • 40. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S, Anıl Yağcıoğlu E.
    Turk Psikiyatri Derg; 2014 Sep 01; 25(3):201-11. PubMed ID: 25219694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.